Antibody-Targeted Therapy (MBI® Training, Bioprocess Industries)

This is a self-paced online course. You'll be able to access lectures and materials when it suits you, over a nine-month period.

The course will cover the following topics:

• Overview of antibody therapeutics field - from discovery to clinical use, including a synopsis of the discovery and development of antibodies (biologics) as therapeutics and regulatory considerations
• Structure and function of antibodies
• Applications of antibodies as therapeutic entities
• Antibody diversity and its relevance in the development and production processes
• Fragments - the structural features of antibody fragments and their recent development as therapeutics
• Antibody drug conjugates (ADCs) - the structural features of ADCs and their recent design and development as novel therapeutics for the oncology market. Also covers the optimisation of the parameters required for the development of clinically useful ADCs
• Bioprocessing - principles of equipment selection and the latest methods for bioprocess manufacture of antibodies in the development process
• Intellectual property - the mechanism and process of intellectual property protection (including antibodies) and real-life examples of the process by which protection can be challenged and lost or won